XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Employee Severance, Litigation, and Other
 9 Months Ended
Jun. 30, 2020
Restructuring and Related Activities [Abstract]  
Employee Severance, Litigation, and Other Employee Severance, Litigation, and Other
        The following illustrates the charges incurred by the Company relating to Employee Severance, Litigation, and Other for the periods indicated:
Three months ended
June 30,		Nine months ended
June 30,
(in thousands)2020201920202019
Employee severance$6,523  $10,815  $32,368  $29,621  
Litigation and opioid-related costs31,369  18,828  86,850  47,189  
Acquisition-related deal and integration costs8,306  12,283  9,109  34,328  
Business transformation efforts9,443  16,289  26,937  33,141  
Other restructuring initiatives2,944  1,791  10,362  11,788  
    Total employee severance, litigation, and other$58,585  $60,006  $165,626  $156,067  

        Employee severance in the three and nine months ended June 30, 2020 included costs primarily related to position eliminations resulting from the Company's decision to permanently exit the PharMEDium compounding business. Employee severance in the three and nine months ended June 30, 2019 included costs primarily related to PharMEDium restructuring activities, position eliminations resulting from the Company's business transformation efforts and the integration of H.D. Smith, and restructuring activities related to its consulting business.

        Litigation and opioid-related costs in the three and nine months ended June 30, 2020 and 2019 related to legal fees in connection with opioid lawsuits and investigations.
        Acquisition-related deal and integration costs in the three and nine months ended June 30, 2019 primarily related to the integration of H.D. Smith. Integration costs primarily included costs to transition servicing legacy H.D. Smith customers to existing Company distribution facilities and operating systems.

        Business transformation efforts in the three and nine months ended June 30, 2020 and 2019 primarily related to costs associated with reorganizing the Company to further align the organization to its customers' needs. The majority of these costs related to services provided by third-party consultants, including certain technology initiatives.